Panel Upholds Dismissal Of False Claims Act Suit Over Isocyanate's Risks

WASHINGTON, D.C.- A District of Columbia Circuit U.S. Court of Appeals panel on July 5 affirmed the dismissal of a law firm's False Claims Act (FCA) lawsuit against companies that manufactured products containing isocyanate, holding that the companies could not face liability under the FCA for allegedly failing to comply with the Toxic Substances Control Act's (TSCA) reporting requirements about the danger to humans associated with the chemical (United States, ex rel. Kasowitz Benson Torres LLP v. BASF Corporation, et al., No. 18-7123, D.C. Cir., 2019 U.S. App. LEXIS 20056).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news